FDA Regulation Of Mifepristone ‘Subverts’ Dobbs, Plaintiffs Tell 5th Circuit

Mealey's (May 11, 2023, 10:52 AM EDT) -- NEW ORLEANS — Eight anti-abortion plaintiffs tell the Fifth Circuit U.S. Court of Appeals that the Food and Drug Administration’s approval and regulation of the abortion drug mifepristone subverts Dobbs v. Jackson Women’s Health Organization in which they say the U.S. Supreme Court “returned to the people the power to protect women’s health, unborn life, and the integrity of the medical profession by regulating abortion.”...